Africa Malaria Treatment Market, By Treatment (Prescription Medications, Vaccines, Diagnostic Tests and Others), By Drug Type (Branded and Generic), By Route of Administration (Oral and Parental, Intravenous), By Distribution Channel (Direct Tender, Hospi

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,599	235 Pages	BlueWeave Consulting	February, 2024	BLWC18632521

Best Price Guarantee
Price	from $3,599
Length	235 Pages
Publisher	BlueWeave Consulting
Published Date	February, 2024
SKU	BLWC18632521

Africa Malaria Treatment Market, By Treatment (Prescription Medications, Vaccines, Diagnostic Tests and Others), By Drug Type (Branded and Generic), By Route of Administration (Oral and Parental, Intravenous), By Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), By End User (Hospitals, Specialty Clinics, Home care and Others), By Country (South Africa, Nigeria, Algeria, Rest of Africa), Trend Analysis, Competitive Landscape & Forecast, 2019–2030

Africa Malaria Treatment Market Size Set Expands at Significant CAGR of 3.54% During 2024–2030 to Reach USD 124.54 Million by 2030
Treatment and prevention for malaria are highly sought after due to the disease's high incidence. Africa's population is expanding quickly. There are more people at risk of catching malaria as the population grows.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Africa Malaria Treatment Market size at USD 108.93 Million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Africa Malaria Treatment Market size to expand at a CAGR of 3.54% reaching a value of USD 124.54 Million by 2030. The government's expanded awareness efforts and the quick development of antimalarial medicine development are the main factors driving the market for malaria treatments in Africa. In sub-Saharan Africa in 2022, 59% of children with fevers sought advice or medical help from a facility or practitioner. There are variations in the behaviour of sick children seeking medical attention based on their residential location; children living in cities are more likely to be admitted than those in rural areas.

Opportunity: Advancement in diagnostic tools

Advanced diagnostic tools, including rapid diagnostic tests (RDTs) and molecular diagnostic techniques, enable early detection of malaria infections. Early diagnosis allows for timely initiation of treatment, reducing the severity of the disease and the risk of complications. Many advanced diagnostic tools are designed for point-of-care testing, allowing healthcare providers to perform rapid and on-site malaria testing. This is particularly beneficial in resource-limited settings where access to centralized laboratories may be limited.
Impact of Geopolitical Tensions on Africa Malaria Treatment Market

Healthcare services can be disrupted by geopolitical tensions, conflicts, and instability. This involves the suspension of regular medical care, disease monitoring, and the provision of necessary medications, such as antimalarial medications. The difficulties in quickly diagnosing and treating malaria can be made worse by disruptions in the provision of healthcare services. Humanitarian crises can be caused by or result from geopolitical conflicts, uprooting populations and putting a burden on the healthcare system already in place. Under such circumstances, it becomes more difficult to provide consistent and effective malaria treatment, which increases the susceptibility of impacted communities.
Africa Malaria Treatment Market
Segmental Information
Africa Malaria Treatment Market - By Treatment
Based on treatment, due to Africa's high malaria case burden—the majority of which are caused by the Plasmodium falciparum parasite—the prescription drug segment is anticipated to hold a sizable proportion of the market during the projected period. Because malaria is an endemic disease, it is imperative to have access to appropriate prescription medications for the treatment and management of the illness. Malaria cases are being diagnosed and treated at a higher rate in several African countries thanks to initiatives to upgrade the infrastructure and accessibility of healthcare. Prescription drug demand is rising as more people have access to healthcare facilities and as part of a comprehensive malaria treatment plan.

Competitive Landscape

The Africa Malaria Treatment Market is fragmented, with numerous players serving the market. The key players dominating the Africa Malaria Treatment Market include Cipla Ltd, Sun Pharmaceutical Industries Ltd, Sanofi SA, GSK Plc, Novartis, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Zydus Cadila, Bliss GVS Pharma Ltd. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Africa Malaria Treatment Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Africa Malaria Treatment Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Product Overview; 1.3. Market Segmentation
2. Executive Summary
3. Africa Malaria Treatment Market Insights: 3.1. Industry Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. High prevalence of malaria; 3.2.1.2. Malaria elimination programs; 3.2.1.3. Rising research and development activities; 3.2.1.4. Improved patient compliance; 3.2.2. Restraints; 3.2.2.1. Drug resistance; 3.2.2.2. Limited access to healthcare; 3.2.3. Opportunities; 3.2.3.1. Focus on affordable and accessible treatments; 3.2.3.2. Advancement in diagnostic tools; 3.2.4. Challenges; 3.2.4.1. Lack of awareness and behavior change; 3.2.4.2. Environmental and climate change; 3.3. Technology Advancements/Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Africa Malaria Treatment Market: Marketing Strategies
5. Africa Malaria Treatment Market Overview: 5.1. Market Size & Forecast, 2019–2030; 5.1.1. By Value (USD Million); 5.2. Market Share & Forecast; 5.2.1. By Treatment; 5.2.1.1. Prescription Medications; 5.2.1.2. Vaccines; 5.2.1.3. Diagnostic Tests; 5.2.1.4. Others; 5.2.2. By Drug Type; 5.2.2.1. Branded; 5.2.2.2. Generic; 5.2.3. By Route of Administration; 5.2.3.1. Oral and Parental; 5.2.3.2. Intravenous; 5.2.4. By Distribution Channel; 5.2.4.1. Direct Tender; 5.2.4.2. Hospital Pharmacies; 5.2.4.3. Retail Pharmacies; 5.2.4.4. Online Pharmacies; 5.2.4.5. Others; 5.2.5. By End User; 5.2.5.1. Hospitals; 5.2.5.2. Specialty Clinics; 5.2.5.3. Home care; 5.2.5.4. Others; 5.2.6. By Country; 5.2.6.1. South Africa; 5.2.6.2. Nigeria; 5.2.6.3. Algeria; 5.2.6.4. Rest of Africa
6. South Africa Malaria Treatment Market: 6.1. Market Size & Forecast, 2019-2029; 6.1.1. By Value (USD Million); 6.2. Market Share & Forecast; 6.2.1. By Treatment; 6.2.2. By Drug Type; 6.2.3. By Route of Administration; 6.2.4. By Distribution Channel; 6.2.5. By End User
7. Nigeria Malaria Treatment Market: 7.1. Market Size & Forecast, 2019-2029; 7.1.1. By Value (USD Million); 7.2. Market Share & Forecast; 7.2.1. By Treatment; 7.2.2. By Drug Type; 7.2.3. By Route of Administration; 7.2.4. By Distribution Channel; 7.2.5. By End User
8. Algeria Malaria Treatment Market: 8.1. Market Size & Forecast, 2019-2029; 8.1.1. By Value (USD Million); 8.2. Market Share & Forecast; 8.2.1. By Treatment; 8.2.2. By Drug Type; 8.2.3. By Route of Administration; 8.2.4. By Distribution Channel; 8.2.5. By End User
9. Rest of Africa Malaria Treatment Market: 9.1. Market Size & Forecast, 2019-2029; 9.1.1. By Value (USD Million); 9.2. Market Share & Forecast; 9.2.1. By Treatment; 9.2.2. By Drug Type; 9.2.3. By Route of Administration; 9.2.4. By Distribution Channel; 9.2.5. By End User
10. Competitive Landscape: 10.1. List of Key Players and Their Offerings; 10.2. Africa Malaria Treatment Company Market Share Analysis, 2023; 10.3. Competitive Benchmarking, By Operating Parameters; 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Escalating Geopolitical Tension on Africa Malaria Treatment Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 12.1. Cipla Ltd; 12.2. Sun Pharmaceutical Industries Ltd; 12.3. Sanofi SA; 12.4. GSK Plc; 12.5. Novartis; 12.6. Hikma Pharmaceuticals PLC; 12.7. Sun Pharmaceutical Industries Ltd.; 12.8. Zydus Cadila; 12.9. Bliss GVS Pharma Ltd.; 12.10. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology: 14.1. Qualitative Research; 14.1.1. Primary & Secondary Research; 14.2. Quantitative Research; 14.3. Market Breakdown & Data Triangulation; 14.3.1. Secondary Research; 14.3.2. Primary Research; 14.4. Breakdown of Primary Research Respondents, By Region; 14.5. Assumptions & Limitations; *Financial information of case of non-listed companies can be provided as per availability.; **The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable.; List of Figures; Figure 1 Africa Malaria Treatment Segmentation; Figure 2 Africa Malaria Treatment Market Value Chain Analysis; Figure 3 Company Market Share Analysis, 2023; Figure 4 Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Figure 5 Africa Malaria Treatment Market Share, By Treatment , By Value, 2019-2030; Figure 6 Africa Malaria Treatment Market Share, By Drug Types, By Value, 2019-2030; Figure 7 Africa Malaria Treatment Market Share, By Route of Administration, By Value, 2019-2030; Figure 8 Africa Malaria Treatment Market Share, By Distribution Channel, By Value, 2019-2030; Figure 9 Africa Malaria Treatment Market Share, By End User, By Value, 2019-2030; Figure 10 Africa Malaria Treatment Market Share, By Country, By Value, 2019-2030; Figure 11 South Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Figure 12 South Africa Malaria Treatment Market Share, By Treatment , By Value, 2019-2030; Figure 13 South Africa Malaria Treatment Market Share, By Drug Types, By Value, 2019-2030; Figure 14 South Africa Malaria Treatment Market Share, By Route of Administration, By Value, 2019-2030; Figure 15 South Africa Malaria Treatment Market Share, By Distribution Channel, By Value, 2019-2030; Figure 16 South Africa Malaria Treatment Market Share, By End User, By Value, 2019-2030; Figure 17 Nigeria Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Figure 18 Nigeria Malaria Treatment Market Share, By Treatment , By Value, 2019-2030; Figure 19 Nigeria Malaria Treatment Market Share, By Drug Types, By Value, 2019-2030; Figure 20 Nigeria Malaria Treatment Market Share, By Route of Administration, By Value, 2019-2030; Figure 21 Nigeria Malaria Treatment Market Share, By Distribution Channel, By Value, 2019-2030; Figure 22 Nigeria Malaria Treatment Market Share, By End User, By Value, 2019-2030; Figure 23 Algeria Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Figure 24 Algeria Malaria Treatment Market Share, By Treatment , By Value, 2019-2030; Figure 25 Algeria Malaria Treatment Market Share, By Drug Types, By Value, 2019-2030; Figure 26 Algeria Malaria Treatment Market Share, By Route of Administration, By Value, 2019-2030; Figure 27 Algeria Malaria Treatment Market Share, By Distribution Channel, By Value, 2019-2030; Figure 28 Algeria Malaria Treatment Market Share, By End User, By Value, 2019-2030; Figure 29 Rest of Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Figure 30 Rest of Africa Malaria Treatment Market Share, By Treatment , By Value, 2019-2030; Figure 31 Rest of Africa Malaria Treatment Market Share, By Drug Types, By Value, 2019-2030; Figure 32 Rest of Africa Malaria Treatment Market Share, By Route of Administration, By Value, 2019-2030; Figure 33 Rest of Africa Malaria Treatment Market Share, By Distribution Channel, By Value, 2019-2030; Figure 34 Rest of Africa Malaria Treatment Market Share, By End User, By Value, 2019-2030; List of Tables; Table 1 Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Table 2 Africa Malaria Treatment Market Size, By Treatment , By Value, 2019-2030; Table 3 Africa Malaria Treatment Market Size, By Drug Types, By Value, 2019-2030; Table 4 Africa Malaria Treatment Market Size, By Route of Administration, By Value, 2019-2030; Table 5 Africa Malaria Treatment Market Size, By Distribution Channel, By Value, 2019-2030; Table 6 Africa Malaria Treatment Market Size, By End User, By Value, 2019-2030; Table 7 Africa Malaria Treatment Market Size, By Country, By Value, 2019-2030; Table 8 South Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Table 9 South Africa Malaria Treatment Market Size, By Treatment , By Value, 2019-2030; Table 10 South Africa Malaria Treatment Market Size, By Drug Types, By Value, 2019-2030; Table 11 South Africa Malaria Treatment Market Size, By Route of Administration, By Value, 2019-2030; Table 12 South Africa Malaria Treatment Market Size, By Distribution Channel, By Value, 2019-2030; Table 13 South Africa Malaria Treatment Market Size, By End User, By Value, 2019-2030; Table 14 Nigeria Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Table 15 Nigeria Malaria Treatment Market Size, By Treatment , By Value, 2019-2030; Table 16 Nigeria Malaria Treatment Market Size, By Drug Types, By Value, 2019-2030; Table 17 Nigeria Malaria Treatment Market Size, By Route of Administration, By Value, 2019-2030; Table 18 Nigeria Malaria Treatment Market Size, By Distribution Channel, By Value, 2019-2030; Table 19 Nigeria Malaria Treatment Market Size, By End User, By Value, 2019-2030; Table 20 Algeria Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Table 21 Algeria Malaria Treatment Market Size, By Treatment , By Value, 2019-2030; Table 22 Algeria Malaria Treatment Market Size, By Drug Types, By Value, 2019-2030; Table 23 Algeria Malaria Treatment Market Size, By Route of Administration, By Value, 2019-2030; Table 24 Algeria Malaria Treatment Market Size, By Distribution Channel, By Value, 2019-2030; Table 25 Algeria Malaria Treatment Market Size, By End User, By Value, 2019-2030; Table 26 Rest of Africa Malaria Treatment Market Size, By Value (USD Million), 2019-2030; Table 27 Rest of Africa Malaria Treatment Market Size, By Treatment , By Value, 2019-2030; Table 28 Rest of Africa Malaria Treatment Market Size, By Drug Types, By Value, 2019-2030; Table 29 Rest of Africa Malaria Treatment Market Size, By Route of Administration, By Value, 2019-2030; Table 30 Rest of Africa Malaria Treatment Market Size, By Distribution Channel, By Value, 2019-2030; Table 31 Rest of Africa Malaria Treatment Market Size, By End User, By Value, 2019-2030; Table 32 Cipla Ltd Company Overview; Table 33 Cipla Ltd Financial Overview; Table 34 Sun Pharmaceutical Industries Ltd Company Overview; Table 35 Sun Pharmaceutical Industries Ltd Financial Overview; Table 36 Sanofi SA Company Overview; Table 37 Sanofi SA Financial Overview; Table 38 GSK Plc Company Overview; Table 39 GSK Plc Financial Overview; Table 40 Novartis Company Overview; Table 41 Novartis Financial Overview; Table 42 Hikma Pharmaceuticals PLC Company Overview; Table 43 Hikma Pharmaceuticals PLC Financial Overview; Table 44 Sun Pharmaceutical Industries Ltd. Company Overview; Table 45 Sun Pharmaceutical Industries Ltd. Financial Overview; Table 46 Zydus Cadila Company Overview; Table 47 Zydus Cadila Financial Overview; Table 48 Bliss GVS Pharma Ltd. Company Overview; Table 49 Bliss GVS Pharma Ltd. Financial Overview